MULTIPLE MYELOMA (MM) REFRACTORY TO LENALIDOMIDE: A SYSTEMATIC LITERATURE REVIEW (SLR) OF RANDOMISED CONTROLLED TRIALS (RCTS)

被引：0
|
作者：
McNamara, S. [1 ]
Kazeem, G. [1 ]
Carter, J. A. [2 ]
Bitetti, J. [3 ]
Wang, P. F. [4 ]
机构：
[1] GSK, Stevenage, Herts, England
[2] Open Hlth, Bethesda, MD USA
[3] GSK, Zug, Switzerland
[4] GSK, Collegeville, PA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO101
引用
收藏
页码：S33 / S33
页数：1
相关论文
共 50 条
  • [31] Thromboprophylaxis in Multiple Myeloma Patients Treated with Lenalidomide - a Systematic Review
    Al-Ani, Fatimah
    Louzada, Martha L.
    Bastida Bermejo, Jose Maria
    Victoria Mateos, Maria
    BLOOD, 2015, 126 (23)
  • [32] Prevalence of Exclusion Criteria in Multiple Myeloma Randomized Controlled Trials: A Systematic Review
    White, Joshua
    Zhukovsky, Sara
    Cliff, Edward R. Scheffer
    Chakraborty, Rajshekhar
    Costa, Luciano
    Van Oekelen, Oliver
    Sborov, Doug
    Mohyuddin, Ghulam Rehman
    BLOOD, 2023, 142
  • [33] Outcomes in randomized controlled trials of therapeutic interventions for multiple myeloma: A systematic review
    Mainou, Maria
    Tsapa, Kalliopi
    Michailidis, Theodoros
    Malandris, Konstantinos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Liakos, Aris
    Papaioannou, Maria
    Terpos, Evangelos
    Prasad, Vinay
    Tsapas, Apostolos
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 204
  • [34] Evolving Unmet Need in Patients Refractory to Lenalidomide: Overview of the Clinical Trials in Relapsed/Refractory Multiple Myeloma
    Mateos, Maria-Victoria
    Medhekar, Rohan
    Majer, Istvan
    Turgut, Mehmet
    BLOOD, 2020, 136
  • [35] A systematic mapping review of Randomized Controlled Trials (RCTs) in care homes
    Adam L Gordon
    Phillipa A Logan
    Rob G Jones
    Calum Forrester-Paton
    Jonathan P Mamo
    John RF Gladman
    BMC Geriatrics, 12
  • [36] A systematic mapping review of Randomized Controlled Trials (RCTs) in care homes
    Gordon, Adam L.
    Logan, Phillipa A.
    Jones, Rob G.
    Forrester-Paton, Calum
    Mamo, Jonathan P.
    Gladman, John R. F.
    BMC GERIATRICS, 2012, 12
  • [37] Treatment Efficacy for Relapsed and Refractory Multiple Myeloma Patients With Gain or Amplification of 1q21: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
    Zhou, Xia
    Hao, Hongyuan
    Wu, Hongying
    Hao, Lumei
    Wei, Liyan
    Li, Xuemei
    Yin, Junjing
    Yu, Qianru
    Xie, Zhanzhi
    Yuan, Chenglu
    Zhong, Yuping
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S473 - S473
  • [38] A phase I trial of ruxolitinib, lenalidomide, and methylprednisolone for patients with relapsed/refractory multiple myeloma (MM).
    Berenson, James R.
    To, Jennifer
    Spektor, Tanya M.
    Martinez, Daisy
    Sanchez, Armando Jose
    Ghermezi, Matthew
    Turner, Carley
    Swift, Regina A.
    Eades, Benjamin M.
    Schwartz, Gary
    Eshaghian, Shahrooz
    Stampleman, Laura
    Moss, Robert A.
    Nassir, Youram
    Patel, Ravindranath
    Bessudo, Alberto
    Lim, Stephen
    Vescio, Robert A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [39] The effect of exercise interventions on quality of life in patients with multiple myeloma: a systematic review and meta-analysis of randomised controlled trials
    Goodhew, Rebecca E.
    Edwards, Ben A.
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (07) : 3217 - 3230
  • [40] The effect of exercise interventions on quality of life in patients with multiple myeloma: a systematic review and meta-analysis of randomised controlled trials
    Rebecca E. Goodhew
    Ben A. Edwards
    Clinical and Experimental Medicine, 2023, 23 : 3217 - 3230
12345